1. Home
  2. ZVRA

as 01-21-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Founded: 2006 Country:
United States
United States
Employees: N/A City: CELEBRATION
Market Cap: 458.5M IPO Year: 2015
Target Price: $21.20 AVG Volume (30 days): 492.6K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.11 EPS Growth: N/A
52 Week Low/High: $4.20 - $9.76 Next Earning Date: 11-12-2024
Revenue: $24,489,000 Revenue Growth: 47.85%
Revenue Growth (this year): -24.57% Revenue Growth (next year): 384.62%

ZVRA Daily Stock ML Predictions

Share on Social Networks: